Hong Kong has been identified as a significant hub for cancer research and medical innovation, according to Cary Adams, CEO of the Union for International Cancer Control (UICC). During the recent World Cancer Congress, which was hosted in the city for the first time, Adams emphasized that Hong Kong is playing a central role in regional breakthroughs.

Beyond research, the UICC highlighted Hong Kong’s public health strategy as a success story. Adams specifically pointed to the city’s effective tobacco control measures, noting that the reduction in smoking rates serves as a practical example for other nations to follow. The congress served as a platform to showcase these efforts to a global audience, reinforcing the city's status within the international medical community. While the report focuses on the positive reception of the city's policies, it underscores the importance of integrating research breakthroughs with proactive public health initiatives to combat cancer effectively.